Commonwealth Equity Services’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-70,956
| Closed | -$432K | – | 3797 |
|
|
2021
Q3 | $432K | Sell |
70,956
-2,229
| -3% | -$13.9K | ﹤0.01% | 2583 |
|
|
2021
Q2 | $602K | Buy |
73,185
+5,229
| +8% | +$44.5K | ﹤0.01% | 2325 |
|
|
2021
Q1 | $608K | Sell |
67,956
-4,060
| -6% | -$46.5K | ﹤0.01% | 2170 |
|
|
2020
Q4 | $831K | Buy |
72,016
+460
| +0.6% | +$5.35K | ﹤0.01% | 1783 |
|
|
2020
Q3 | $744K | Hold |
71,556
| – | – | ﹤0.01% | 1683 |
|
|
2020
Q2 | $940K | Buy |
71,556
+10,256
| +17% | +$106K | ﹤0.01% | 1459 |
|
|
2020
Q1 | $482K | Buy |
61,300
+4,130
| +7% | +$62.2K | ﹤0.01% | 1720 |
|
|
2019
Q4 | $1.18M | Hold |
57,170
| – | – | ﹤0.01% | 1317 |
|
|
2019
Q3 | $783K | Buy |
57,170
+5,697
| +11% | +$67.6K | ﹤0.01% | 1515 |
|
|
2019
Q2 | $633K | Buy |
51,473
+4,312
| +9% | +$49.7K | ﹤0.01% | 1637 |
|
|
2019
Q1 | $588K | Buy |
47,161
+4,796
| +11% | +$64.1K | ﹤0.01% | 1636 |
|
|
2018
Q4 | $479K | Buy |
42,365
+4,000
| +10% | +$62.7K | ﹤0.01% | 1676 |
|
|
2018
Q3 | $717K | Buy |
38,365
+10,000
| +35% | +$230K | ﹤0.01% | 1530 |
|
|
2018
Q2 | $733K | Sell |
28,365
-400
| -1% | -$10.4K | ﹤0.01% | 1483 |
|
|
2018
Q1 | $644K | Sell |
28,765
-202
| -0.7% | -$4.93K | ﹤0.01% | 1531 |
|
|
2017
Q4 | $725K | Buy |
28,967
+402
| +1% | +$9.84K | ﹤0.01% | 1422 |
|
|
2017
Q3 | $691K | Hold |
28,565
| – | – | ﹤0.01% | 1399 |
|
|
2017
Q2 | $578K | Buy |
28,565
+5,925
| +26% | +$123K | ﹤0.01% | 1477 |
|
|
2017
Q1 | $609K | Buy |
22,640
+1,300
| +6% | +$26.5K | ﹤0.01% | 1393 |
|
|
2016
Q4 | $406K | Buy |
21,340
+5,920
| +38% | +$113K | ﹤0.01% | 1536 |
|
|
2016
Q3 | $301K | Sell |
15,420
-1,347
| -8% | -$22.8K | ﹤0.01% | 1721 |
|
|
2016
Q2 | $251K | Buy |
+16,767
| New | +$211K | ﹤0.01% | 1793 |
|